Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
Federica PecciLuca CantiniValeria CognigniFabiana PerroneGiulia MazzaschiVeronica AgostinelliGiulia MentrastiElda FavariMichele MaffezzoliAlessio CortelliniFrancesca RossiRebecca ChiariottiFrancesco Maria VenanziGiuseppe Lo RussoGiulia GalliClaudia ProtoMonica GanzinelliFrancesca TronconiFrancesca MorgeseCarla CampolucciMarco MorettiArianna VigniniMarcello TiseoRoberta MinariMarco Luigi Bruno RocchiSebastiano ButiRossana BerardiPublished in: The oncologist (2023)
We developed a lipid score that defined subgroups of patients with cancer who differently benefit from ICIs. Further mechanistic insights are warranted to clarify the prognostic and predictive role of lipid profile components in patients treated with ICIs.